Market Cap 414.47M
Revenue (ttm) 0.00
Net Income (ttm) -20.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,417,500
Avg Vol 1,048,500
Day's Range N/A - N/A
Shares Out 113.24M
Stochastic %K 21%
Beta 1.25
Analysts Strong Buy
Price Target $10.00

Company Profile

Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The com...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 427 2727
Address:
Three Columbus Circle, 15th Floor, New York, United States
Lanuchbox
Lanuchbox Jun. 9 at 12:46 AM
$INDP Check out this great informative video on this company https://youtu.be/wd3GyuAtVII?si=z-hLwe1gqjGZBZpq
0 · Reply
Petros_Marinakou
Petros_Marinakou Jun. 8 at 9:06 PM
$INDP the stock is a game people,  the Bulls run straight up and then the same bulls  where are the bears mask and tank it. You just have to be good enough to be on the right side up or down.
0 · Reply
Flyfish15
Flyfish15 Jun. 8 at 8:50 PM
$INDP Why is this up huge after hours with the big drop during the day? Anyone?
0 · Reply
TheTinyDevil
TheTinyDevil Jun. 8 at 7:56 PM
$INDP 42% drop and virtually ZERO board chatter??!! Hmmmm.....
1 · Reply
SpudZone
SpudZone Jun. 8 at 7:36 PM
Small cap watches into close: $SMTK $NPT $INDP $SUNE
0 · Reply
IBBullish
IBBullish Jun. 8 at 7:29 PM
0 · Reply
Igrisu
Igrisu Jun. 8 at 2:23 PM
$RKTO Got out at 1.85 last week (Entry was 1.29) Currently in $LASE and $INDP Lase entry 3.02 INDP entry 3.38 Shoot a follow for anyone interested in my plays. Good luck yall. Make that money 💰
0 · Reply
Rampageusa
Rampageusa Jun. 8 at 1:43 PM
$INDP slow climb back to 5/6….
1 · Reply
SqueezeRib
SqueezeRib Jun. 8 at 1:34 PM
$INDP $7 🧲🧲🧲
0 · Reply
PraxisTrade
PraxisTrade Jun. 8 at 10:09 AM
0 · Reply
Latest News on INDP
Indaptus Therapeutics Quarterly report: Q1 2026

May 15, 2026, 8:00 AM EDT - 24 days ago

Indaptus Therapeutics Quarterly report: Q1 2026


Indaptus Therapeutics Earnings release: Q1 2026

May 15, 2026, 8:00 AM EDT - 24 days ago

Indaptus Therapeutics Earnings release: Q1 2026


Indaptus Therapeutics Annual report: Q4 2025

Mar 17, 2026, 8:00 AM EDT - 2 months ago

Indaptus Therapeutics Annual report: Q4 2025


Indaptus Therapeutics Proxy statement: Proxy filing

Feb 12, 2026, 7:00 AM EST - 4 months ago

Indaptus Therapeutics Proxy statement: Proxy filing


Indaptus Therapeutics Proxy statement: Proxy filing

Jan 21, 2026, 7:00 AM EST - 4 months ago

Indaptus Therapeutics Proxy statement: Proxy filing


Indaptus Therapeutics Proxy statement: Proxy filing

Jan 8, 2026, 7:00 AM EST - 5 months ago

Indaptus Therapeutics Proxy statement: Proxy filing


Indaptus Therapeutics Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 7 months ago

Indaptus Therapeutics Quarterly report: Q3 2025


Indaptus Therapeutics Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 7 months ago

Indaptus Therapeutics Earnings release: Q3 2025


Indaptus Therapeutics Provides Clinical Update

Sep 4, 2025, 4:01 PM EDT - 9 months ago

Indaptus Therapeutics Provides Clinical Update


Indaptus Therapeutics files $200M mixed securities shelf

2025-08-13T20:26:36.000Z - 10 months ago

Indaptus Therapeutics files $200M mixed securities shelf


Indaptus Therapeutics Registration statement: Registration filing

Aug 13, 2025, 8:00 AM EDT - 10 months ago

Indaptus Therapeutics Registration statement: Registration filing


Indaptus Therapeutics Registration statement: Registration filing

Aug 13, 2025, 8:00 AM EDT - 10 months ago

Indaptus Therapeutics Registration statement: Registration filing


Indaptus Therapeutics Quarterly report: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 10 months ago

Indaptus Therapeutics Quarterly report: Q2 2025


Indaptus Therapeutics Earnings release: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 10 months ago

Indaptus Therapeutics Earnings release: Q2 2025


Indaptus Therapeutics Inc trading resumes

2025-06-27T14:10:13.000Z - 1 year ago

Indaptus Therapeutics Inc trading resumes


Indaptus Therapeutics Inc trading halted, news pending

2025-06-26T23:50:25.000Z - 1 year ago

Indaptus Therapeutics Inc trading halted, news pending


Indaptus Therapeutics Announces Reverse Stock Split

Jun 25, 2025, 7:00 AM EDT - 1 year ago

Indaptus Therapeutics Announces Reverse Stock Split


Indaptus Therapeutics Proxy statement: Proxy filing

Jun 23, 2025, 8:00 AM EDT - 1 year ago

Indaptus Therapeutics Proxy statement: Proxy filing


Indaptus Therapeutics Proxy statement: Proxy filing

Jun 13, 2025, 8:00 AM EDT - 1 year ago

Indaptus Therapeutics Proxy statement: Proxy filing


Indaptus Therapeutics Quarterly report: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

Indaptus Therapeutics Quarterly report: Q1 2025


Indaptus Therapeutics Earnings release: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

Indaptus Therapeutics Earnings release: Q1 2025


Indaptus Therapeutics Slides: Investor presentation

May 14, 2025, 7:00 AM EDT - 1 year ago

Indaptus Therapeutics Slides: Investor presentation


Indaptus Therapeutics Proxy statement: Proxy filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Indaptus Therapeutics Proxy statement: Proxy filing


Indaptus Therapeutics Proxy statement: Proxy filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Indaptus Therapeutics Proxy statement: Proxy filing


Indaptus Therapeutics Proxy statement: Proxy filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Indaptus Therapeutics Proxy statement: Proxy filing


Indaptus Therapeutics initiates Phase 1 study of Decoy20

2025-03-18T12:20:25.000Z - 1 year ago

Indaptus Therapeutics initiates Phase 1 study of Decoy20


Indaptus Therapeutics Annual report: Q4 2024

Mar 13, 2025, 8:00 AM EDT - 1 year ago

Indaptus Therapeutics Annual report: Q4 2024


Indaptus Therapeutics Earnings release: Q4 2024

Mar 13, 2025, 8:00 AM EDT - 1 year ago

Indaptus Therapeutics Earnings release: Q4 2024


Indaptus Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Indaptus Therapeutics Quarterly report: Q3 2024


Indaptus Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Indaptus Therapeutics Earnings release: Q3 2024


Indaptus Therapeutics Quarterly report: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 1 year ago

Indaptus Therapeutics Quarterly report: Q2 2024


Indaptus Therapeutics Earnings release: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 1 year ago

Indaptus Therapeutics Earnings release: Q2 2024


Indaptus Therapeutics Quarterly report: Q1 2024

May 8, 2024, 8:00 AM EDT - 2 years ago

Indaptus Therapeutics Quarterly report: Q1 2024


Indaptus Therapeutics Earnings release: Q1 2024

May 8, 2024, 8:00 AM EDT - 2 years ago

Indaptus Therapeutics Earnings release: Q1 2024


Indaptus Therapeutics Proxy statement: Proxy filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Indaptus Therapeutics Proxy statement: Proxy filing


Indaptus Therapeutics Proxy statement: Proxy filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Indaptus Therapeutics Proxy statement: Proxy filing


Indaptus Therapeutics Annual report: Q4 2023

Mar 13, 2024, 8:00 AM EDT - 2 years ago

Indaptus Therapeutics Annual report: Q4 2023


Indaptus Therapeutics Earnings release: Q4 2023

Mar 13, 2024, 8:00 AM EDT - 2 years ago

Indaptus Therapeutics Earnings release: Q4 2023


Indaptus Therapeutics Quarterly report: Q3 2023

Nov 6, 2023, 7:00 AM EST - 2 years ago

Indaptus Therapeutics Quarterly report: Q3 2023


Indaptus Therapeutics Earnings release: Q3 2023

Nov 6, 2023, 7:00 AM EST - 2 years ago

Indaptus Therapeutics Earnings release: Q3 2023


Indaptus Therapeutics Quarterly report: Q2 2023

Aug 14, 2023, 8:00 AM EDT - 3 years ago

Indaptus Therapeutics Quarterly report: Q2 2023


Indaptus Therapeutics Earnings release: Q2 2023

Aug 14, 2023, 8:00 AM EDT - 3 years ago

Indaptus Therapeutics Earnings release: Q2 2023


Indaptus Therapeutics Quarterly report: Q1 2023

May 11, 2023, 8:00 AM EDT - 3 years ago

Indaptus Therapeutics Quarterly report: Q1 2023


Indaptus Therapeutics Earnings release: Q1 2023

May 11, 2023, 8:00 AM EDT - 3 years ago

Indaptus Therapeutics Earnings release: Q1 2023


Indaptus Therapeutics Proxy statement: Proxy filing

Apr 12, 2023, 8:00 AM EDT - 3 years ago

Indaptus Therapeutics Proxy statement: Proxy filing


Indaptus Therapeutics Proxy statement: Proxy filing

Apr 12, 2023, 8:00 AM EDT - 3 years ago

Indaptus Therapeutics Proxy statement: Proxy filing


Indaptus Therapeutics Annual report: Q4 2022

Mar 17, 2023, 8:00 AM EDT - 3 years ago

Indaptus Therapeutics Annual report: Q4 2022


Lanuchbox
Lanuchbox Jun. 9 at 12:46 AM
$INDP Check out this great informative video on this company https://youtu.be/wd3GyuAtVII?si=z-hLwe1gqjGZBZpq
0 · Reply
Petros_Marinakou
Petros_Marinakou Jun. 8 at 9:06 PM
$INDP the stock is a game people,  the Bulls run straight up and then the same bulls  where are the bears mask and tank it. You just have to be good enough to be on the right side up or down.
0 · Reply
Flyfish15
Flyfish15 Jun. 8 at 8:50 PM
$INDP Why is this up huge after hours with the big drop during the day? Anyone?
0 · Reply
TheTinyDevil
TheTinyDevil Jun. 8 at 7:56 PM
$INDP 42% drop and virtually ZERO board chatter??!! Hmmmm.....
1 · Reply
SpudZone
SpudZone Jun. 8 at 7:36 PM
Small cap watches into close: $SMTK $NPT $INDP $SUNE
0 · Reply
IBBullish
IBBullish Jun. 8 at 7:29 PM
0 · Reply
Igrisu
Igrisu Jun. 8 at 2:23 PM
$RKTO Got out at 1.85 last week (Entry was 1.29) Currently in $LASE and $INDP Lase entry 3.02 INDP entry 3.38 Shoot a follow for anyone interested in my plays. Good luck yall. Make that money 💰
0 · Reply
Rampageusa
Rampageusa Jun. 8 at 1:43 PM
$INDP slow climb back to 5/6….
1 · Reply
SqueezeRib
SqueezeRib Jun. 8 at 1:34 PM
$INDP $7 🧲🧲🧲
0 · Reply
PraxisTrade
PraxisTrade Jun. 8 at 10:09 AM
0 · Reply
Igrisu
Igrisu Jun. 8 at 8:08 AM
$INDP in at 3.38
0 · Reply
StockScanners
StockScanners Jun. 6 at 11:11 PM
$INDP 2.85 was the level we identified as a key area on the chart. From there, price extended to 4.10, representing a gain of roughly 43.9%. What makes this one stand out is how clearly the market respected that reference point before momentum accelerated. The move itself was impressive, but recognizing the significance of 2.85 beforehand was the real takeaway. These are the types of setups that reinforce the importance of focusing on structure and key levels first. Who else had 2.85 marked before the move?
0 · Reply
focafoca99
focafoca99 Jun. 5 at 8:58 PM
$INDP released director and officer resignation details, with two directors and the COO stepping down.
0 · Reply
TwongStocks
TwongStocks Jun. 5 at 8:38 PM
$INDP David E. Lazar and Avraham Ben-Tzvi resign from the Board of Directors, effective June 5. Lazar had previously sold a majority of his preferred shares to the new ownership group. Walt A. Linscott resigned as COO on June 1, and will serve as a consultant for the company. https://www.sec.gov/ix?doc=/Archives/edgar/data/1857044/000149315226027499/form8-k.htm
0 · Reply
jucebot
jucebot Jun. 5 at 8:12 PM
FJ is in a long on $INDP @ $3.55 $VEEE $WCT
0 · Reply
LaraLobo
LaraLobo Jun. 5 at 8:12 PM
$RMSG On watch for Monday. $INDP looked similar AH's yesterday and took a nice bounce today.
0 · Reply
jucebot
jucebot Jun. 5 at 8:12 PM
FJ stepped into a long on $SMCZ @ $7.37 $INDP $VEEE $WCT
0 · Reply
jucebot
jucebot Jun. 5 at 8:07 PM
FJ just got long on $WCT.X @ $1.41 $INDP $SMCZ $VEEE
0 · Reply
jucebot
jucebot Jun. 5 at 8:07 PM
FJ entered a long on $SMCZ @ $7.35 $INDP $VEEE
1 · Reply
jucebot
jucebot Jun. 5 at 7:28 PM
FJ started a long in $WCT.X @ $1.39 $CDTG $INDP $RMSG $VEEE
0 · Reply
jucebot
jucebot Jun. 5 at 7:26 PM
FJ added a long on $CDTG @ $3.65 $INDP $RMSG $VEEE
1 · Reply
jucebot
jucebot Jun. 5 at 7:25 PM
FJ just locked in a long on $VEEE @ $5.91 $INDP $RMSG
0 · Reply